USD10
TRVI acciones
Acerca de Trevi TherapeuticsTrevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
USD10
TRVI acciones
Acerca de Trevi TherapeuticsTrevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
24 mar at 13:30 GMT+0
CAPITALIZACIÓN DE MERCADO
1344,32 M US$
PRECIO DE APERTURA
No hay suficientes datos
BAJO (1Y)
4,85 US$
ALTO (1Y)
14,39 US$
BAJO (24H)
10,40 US$
Alza (24H)
11,00 US$
Volumen (24 h)
216,00 US$
99,99 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | No hay suficientes datos | No hay suficientes datos |
1 día | 10,72 US$ | |
1 semana | 11,40 US$ | |
1 mes | 11,25 US$ | |
1 año | 6,61 US$ |
Una nueva era de Coinbase ha comenzado
El futuro del dinero está aquí. Sé uno de los primeros en obtener acceso y probar nuevas funciones en cuanto estén disponibles.
Crea una cuenta ahora